Amyloid Angiopathy and Blood–Brain Barrier Changes in Alzheimer's Diseasea,b
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Evidence is accumulating that suggests that increased permeability of the BBB to blood‐borne proteins is favorable for the development of neuropathologic changes such as amyloid angiopathy and formation of amyloid plaques in the AD brain. To study this problem, we applied a quantitative immunocytochemical procedure that enables evaluation of the barrier function of brain microvasculature to endogenous albumin. This procedure was successfully used on scrapie‐infected mice, which represent a unique animal model enabling study of an interrelation between BBB function and deposition of amyloid within vascular wall and neuritic plaques. Biopsy specimens obtained during neurosurgical procedures (tumors and dementia) were also examined. Our observations indicate that (1) the vast majority of brain microvessels in scrapie‐infected mice and in demented individuals show normal features of the BBB; (2) only those microvascular segments directly surrounded by amyloid plaques or representing amyloid angiopathy show increased permeability to endogenous albumin; (3) numerous immunosignals over the amyloid deposits in plaques and in the wall of angiopathic vessels suggest the affinity of extravasated albumin to the amyloid material.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221
Self-citation
Cited by
Alzheimer Disease as a Vascular Disorder: Nosological Evidence
de la Torre, J. C. (2002) · Stroke · doi:10.1161/01.str.0000014421.15948.67 · Cited by 853
The blood–brain barrier in health and disease: Important unanswered questions
Profaci, C. P., Munji, R. N., Pulido, R. S., & Daneman, R. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190062 · Cited by 761
Farkas, E., Luiten, P. G. M., & Bari, F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.003 · Cited by 723
The role of microglia in amyloid clearance from the AD brain
Lee, C. Y. D., & Landreth, G. E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0433-4 · Cited by 701
“However, it is noteworthy that in the later stage of AD, BBB break down has been reported in human patients and mouse models (Kalaria 1997; Skoog et al. 1998; Wisniewski et al. 1997).”
BackgroundAlzheimer's Disease: From Pathology to Therapeutic Approaches
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626
Metadata
- Authors
- WISNIEWSKI, H. M., VORBRODT, A. W., & WEGIEL, J.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 826
- Issue
- 1
- Pages
- 161-172
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2038298070
- Cited by
- 100
- References
- 1
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid Angiopathy and Blood–Brain Barrier Changes in Alzheimer's Diseasea,b. https://app.cochat.ai/papers/10.1111/j.1749-6632.1997.tb48468.x
- The paper
- WISNIEWSKI, H. M., VORBRODT, A. W., & WEGIEL, J. (1997). Amyloid Angiopathy and Blood–Brain Barrier Changes in Alzheimer's Diseasea,b. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48468.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.